Ascendis Pharma (ASND)

Ascendis Pharma (ASND) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ASND last traded at $249.49, -0.71% on the day.
• Ascendis Pharma: market cap $16.53B, P/E 18.4, revenue $1.05B over the last four quarters, next earnings 2026-11-11.
• Over the past year ASND returned 22.47%; year to date 17.00%.

Updated 2026-11-02 19:07 UTC